Effects of Travatan Z and Xalatan on Ocular Surface Health
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, double-masked, parallel-group, multicenter study is to
evaluate ocular surface effects after the administration of travoprost with SofZia®
preservative system or Xalatan once daily for 12 weeks.